Puma Biotechnology Inc. appointed Michael Miller as a director with a term expiring at the 2018 annual meeting of stockholders.
Miller has served as the executive vice president of U.S. commercial at Jazz Pharmaceuticals PLC since May 2017.
Puma Biotechnology appoints director
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Puma Biotechnology Inc. appointed Michael Miller as a director with a term expiring at the 2018 annual meeting of stockholders.
Miller has served as the executive vice president of U.S. commercial at Jazz Pharmaceuticals PLC since May 2017.